Santosh Sutradhar
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)KIIT University(IN)
Publications by Year
Research Areas
Health Systems, Economic Evaluations, Quality of Life, Advanced Breast Cancer Therapies, Blood Pressure and Hypertension Studies, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies
Most-Cited Works
- → The Seattle Heart Failure Model(2006)2,006 cited
- → Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial(2016)467 cited
- → Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2(2018)92 cited
- → Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial(2017)91 cited
- → Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial(2014)73 cited
- → A Double-Blind, Randomized, Controlled, Multicenter Safety and Immunogenicity Study of a Refrigerator-Stable Formulation of Zostavax(2007)62 cited